DeuterOncology
Personen
10
Standorte
1
Veröffentlichungen
10
Unternehmensprofil
Gründungsdatum
28. September 2020
Letztes Bilanzjahr
2024
Rechtsform
Naamloze vennootschap
Unternehmenstyp
Rechtspersoon
Aktivität
21100 - Vervaardiging van farmaceutische grondstoffen
Unternehmensalter
6 Jahre
Kontaktdaten
Unlock direct contact points, registry address detail, and website links for DeuterOncology.
Unlock Contact Details
Reveal email, phone, website, and full registry contact information.
Create Free AccountHistorische Finanzdaten
| KPI | 2024 | 2023 | 2022 |
|---|---|---|---|
| Umsatz | - | - | - |
| Bruttomarge | -1.987.149 € (-6.6%) | -1.864.132 € (+18.8%) | -2.294.417 € (-108.1%) |
| Gewinn | -2.114.850 € (-4.2%) | -2.029.591 € (+15.0%) | -2.387.844 € (-117.0%) |
| EBITDA | -1.825.332 € (-8.4%) | -1.683.632 € (+29.5%) | -2.387.844 € (-117.0%) |
| Eigenkapital | 965.547 € (-43.4%) | 1.707.402 € (-48.4%) | 3.309.968 € (+9465.3%) |
| Schulden | 304.423 € (+13.2%) | 269.011 € (-8.4%) | 293.705 € (-52.9%) |
| Gesamtkapital | 1.271.170 € (-35.7%) | 1.976.413 € (-45.2%) | 3.603.673 € (+513.1%) |
| Barmittel | 829.070 € (-46.6%) | 1.551.443 € (-56.3%) | 3.550.735 € (+567.2%) |
| Vollzeitäquivalente (FTE) | - | - | - |
Unlock Full History
Create a free account to access up to 10 years of historical financial data for DeuterOncology.
Create Free AccountFinanzielle Gesundheit
Ratio-level insight derived from the latest company and balance sheet data.
Current Ratio
3,3x
(-54.9%)
Quick Ratio
3,3x
(-54.9%)
Solvency
76,0%
(-12.1%)
Debt / Equity
0,3x
Unlock Advanced Metrics
Access the full ratio deck, benchmarking signals, and deeper profitability diagnostics.
Create Free AccountStandorte & Präsenz
Establishment
AdresseClos Chanmurly 13, 4000 Luik, Belgium
Unternehmensnetzwerk
First-level relations linked directly to DeuterOncology. Unlock second-level relations for deeper graph exploration.
DeuterOncology
Aktiv
- Newton Biocapital Partners
Incoming link
Administrator Legal - NOSHAQ PARTNERS
Incoming link
Administrator Legal - VIZIPHAR Biosciences
Incoming link
Administrator Legal -
SCRL NOSHAQ PARTNERS
Incoming link
Administrator Natural -
Serge Jean Jacques Sagodira
Incoming link
Administrator Natural -
Thimothy Perera
Incoming link
Administrator Natural -
Tim Perera
Incoming link
Administrator Natural - INVESTSUD TECH
Outgoing link
Participating Interest - Newton Biocapital I, pricaf privée de droit belge
Outgoing link
Participating Interest - OCTIMET Oncology
Incoming link
Participating Interest -
Els Hubloux
Incoming link
Administrator Legal Representative -
Guillaume HEYNEN
Incoming link
Administrator Legal Representative -
Gustaaf Van Reet
Incoming link
Administrator Legal Representative -
Hélène SABATEL
Incoming link
Administrator Legal Representative -
Pierre DETRIXHE
Incoming link
Administrator Legal Representative -
Van REET GUSTAAF
Incoming link
Administrator Legal Representative
Unlock Second-Level Relations
Expand beyond direct links to see second-level entities, people, and cross-company paths.
Free Sign UpVeröffentlichungen im Belgischen Staatsblatt
Management & Schlüsselpersonen
Unlock linked people, governance roles, and enriched demographic signals associated with DeuterOncology.
Management Profiles
Unlock directors, managers, role history, plus inferred gender and age where available.
Create Free Account